About Nuray chemicals
Nuray chemicals is a company based in Thiruvarur (India) founded in 2012 by Muthusamy Shanmugam. It operates as a B2B. The company has 336 employees as of March 31, 2023. Nuray chemicals offers products and services including Atropine Sulfate Monohydrate, Dapsone, Chlorzoxazone, L-Methyl Folate, and Piribedil. Nuray chemicals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Thiruvarur, India
- Employees 336 as on 31 Mar, 2023
- Founders Muthusamy Shanmugam
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nuray Chemicals Private Limited
- Date of Incorporation 14 Jun, 2012
- Jurisdiction Thiruvallur, Tamil Nadu, India
-
Annual Revenue
$10.66 M (USD)10.27as on Mar 31, 2023
-
Net Profit
$171.57 K (USD)-77.34as on Mar 31, 2023
-
EBITDA
$1.09 M (USD)-43.1as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
336
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nuray chemicals
Nuray chemicals offers a comprehensive portfolio of products and services, including Atropine Sulfate Monohydrate, Dapsone, Chlorzoxazone, L-Methyl Folate, and Piribedil.
Active ingredient used in pharmaceuticals for medical applications.
Antibiotic compound for treating bacterial infections.
Muscle relaxant for pain relief purposes.
Nutritional supplement for folate deficiency.
Medication for neurological disorders.
Treatment for copper accumulation diseases.
People of Nuray chemicals
Unlock access to complete
Funding Insights of Nuray chemicals
Detailed funding history for Nuray chemicals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nuray chemicals
Investment portfolio details for Nuray chemicals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nuray chemicals
Detailed financials for Nuray chemicals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuray Chemicals Comparisons
Peer comparison for Nuray chemicals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nuray chemicals
Nuray chemicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Nuray chemicals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuray Chemicals
Complete news archive for Nuray chemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nuray chemicals
Nuray chemicals was founded in 2012.
Nuray chemicals is headquartered in Thiruvarur, India. It is registered at Thiruvarur, Tamil Nadu, India.
Muthusamy Shanmugam is the current CEO of Nuray chemicals. They have also founded this company.
As of Mar 31, 2023, the latest employee count at Nuray chemicals is 336.
Annual revenue of Nuray chemicals is $10.66M as on Mar 31, 2023.
Nuray Chemicals , Established In 2012, Specializes In Developing And Manufacturing Active Pharmaceutical Ingredients (apis) Through Chemical Synthesis And Rd. Based In Tamilnadu, India, With A Presence In The Usa, It Focuses On Quality Compliance And Serves Global Generic Pharmaceutical Companies By Delivering A Diverse Product Portfolio And Innovative Capabilities.
Nuray chemicals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Nuray chemicals offers Atropine Sulfate Monohydrate, Dapsone, Chlorzoxazone, L-Methyl Folate, and 2 more products and services.